EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer

Zhanna Zavgorodneva, Jocelyne Karam

AACE Endocrinology and Diabetes · 2026-09 · 13 (5) · 819-823

DOI: 10.1016/j.aed.2026.06.001 ↗

Kurz gefasst

Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Zhanna Zavgorodneva und 1 weiteren Autor:innen. Beteiligte Einrichtung: SUNY Downstate Health Science University, Brooklyn, New York. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective: Severe hypercalcemia is commonly associated with malignancy and, less frequently, with excessive calcium and vitamin D intake. Management is particularly challenging in patients with underlying disorders of calcium homeostasis. We present a case highlighting the complexities of treating hypercalcemia following discontinuation of denosumab in a patient with malignancy and underlying familial hypocalcemia on long-term calcium supplementation. Case Report: A 70-year-old woman with metastatic breast cancer and underlying familial hypocalcemia on chronic calcium and active vitamin D supplementation presented with hypercalcemic crisis following discontinuation of long-term denosumab therapy. She was treated with intravenous hydration and 2 doses of calcitonin, which led to a rapid decline in serum calcium levels and subsequent profound hypocalcemia requiring reinitiation of supplementation. Shortly after discharge, she was readmitted with recurrent hypercalcemia, again treated with 1 dose of calcitonin, followed by recurrent hypocalcemia. She was ultimately stabilized with careful titration of calcium and active vitamin D therapy.

Discussion

This case highlights several important clinical considerations, including the patient's familial history, oncologic history, the underlying mechanisms contributing to abrupt shifts in calcium levels, and strategies for effective management.

Conclusion

Treating hypercalcemia in patients with underlying hypocalcemia disorders can be challenging. Clinicians should take in consideration the complex pathophysiology of their disorder and monitor calcium closely to prevent hypocalcemia.

Schlagwörter

Stichwörter der Autor:innen

calcitriol supplementfamilial hypocalcemiahypocalcemiasevere hypercalcemia

Autor:innen und Institutionen

  • SUNY Downstate Health Science University, Brooklyn, New York.
  • Division of Endocrinology, Department of Medicine, Maimonides Medical Center, Brooklyn, New York.

Zitieren

APA

Zavgorodneva, Z., & Karam, J. (2026). Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer. AACE Endocrinology and Diabetes, 13(5), 819-823. https://doi.org/10.1016/j.aed.2026.06.001

Vancouver

Zavgorodneva Z, Karam J. Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer. AACE Endocrinology and Diabetes. 2026;13(5):819-823. doi:10.1016/j.aed.2026.06.001

BibTeX
@article{Zavgorodneva2026,
  author = {Zavgorodneva, Zhanna and Karam, Jocelyne},
  title = {Severe Hypercalcemia Followed by Profound Hypocalcemia in a Patient With Familial Hypocalcemia and Metastatic Cancer},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  volume = {13},
  number = {5},
  pages = {819--823},
  doi = {10.1016/j.aed.2026.06.001}
}
Kostenlos starten →